Xylem beats Q1 estimates, raises FY revenue and adjusted EPS guidance

Xylem Inc.

2024-Q1 EPS reported $0.63 revenue$2,033,000,000

Q1 revenue of $2.0B (+40% reported, +7% organic); orders $2.2B (+43% reported, +3% organic).
GAAP EPS $0.63 (+17%); adjusted EPS $0.90 (+14%); net income $153M; adjusted net income $219M.
FY 2024 revenue guidance raised to ~$8.5B (+15-16% reported, +4-6% organic).
Adjusted EPS guidance raised to $4.10-$4.25 from $4.00-$4.20; adjusted EBITDA margin now ~20%.
Record Q1 margins driven by productivity, favorable mix; Evoqua integration on track.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Xylem Inc. reported the quarter ended March 31, 2024 results: revenue $2.0 billion, net income $153 million, EPS $0.63 per share. Guidance raised.

Period: the quarter ended March 31, 2024
Revenue: $2.0 billion
Net income: $153 million
EPS: $0.63 per share
Guidance: raised
Result: reported results

Exact text from the filing

Xylem Reports First Quarter 2024 Results and Raises Full-Year Guidance • Orders of $2.2 billion, up 43% on a reported basis and 3% organically • Revenue of $2.0 billion, up 40% on a reported basis and 7% organically • Earnings per share of $0.63, up 17%; $0.90 on an adjusted basis, up 14% • Raising full-year revenue guidance to approximately

View on SEC.gov

1447 earnings releases filed in the last 30 days. Browse all earnings releases →

Xylem Inc. filing history →

Source: SEC EDGAR

accession 0001524472-24-000013

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.